The effect of some beta-adrenergic receptor blocking drugs on carbohydrate metabolism in mouse brain.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000588:Amines / Q000494:pharmacology; D000818:Animals; D001205:Ascorbic Acid / Q000378:metabolism; D001921:Brain / Q000378:metabolism*; D050260:Carbohydrate Metabolism; D002247:Carbon Isotopes; D004298:Dopamine / Q000378:metabolism; D000431:Ethanol / Q000494:pharmacology; D005260:Female; D005947:Glucose / Q000378:metabolism; D006003:Glycogen / Q000378:metabolism; D006008:Glycogen Storage Disease / Q000188:drug therapy; D006019:Glycolysis / Q000187:drug effects; D007211:Indoles / Q000494:pharmacology; D007274:Injections, Intraperitoneal; D007773:Lactates / Q000378:metabolism / Q000494:pharmacology; D008099:Liver / Q000378:metabolism; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009638:Norepinephrine / Q000378:metabolism; D011433:Propranolol / Q000494:pharmacology; D011773:Pyruvates / Q000378:metabolism; D011802:Quinidine / Q000494:pharmacology; D013565:Sympatholytics / Q000008:administration & dosage / Q000494:pharmacology; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D000588:Amines; D002247:Carbon Isotopes; D007211:Indoles; D007773:Lactates; D011773:Pyruvates; D013565:Sympatholytics; D000431:Ethanol; D006003:Glycogen; D011433:Propranolol; D011802:Quinidine; D005947:Glucose; D001205:Ascorbic Acid; D004298:Dopamine; D009638:Norepinephrine